Edmonton Police Oversight: Reform or Cosmetic Changes?
An in-depth analysis of the pivotal EPS oversight report reveals both promising reforms and concerning gaps in Alberta's police accountability system.
Category : Search result: pharmaceutical oversight
Ontario bypasses public hearings on education power bill
The Ford government is using a legislative maneuver to fast-track controversial education legislation without public hearings, including a bill that would significantly expand the education minister's authority over school boards.
Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
Budget 2025 Cuts Intelligence Watchdog Funds
Canada's 2025 federal budget reveals significant cuts to intelligence oversight agencies, raising concerns about transparency and accountability in national security operations.
Alberta Seeks New Auditor General Amid Extension Offer
Alberta's government is launching a search for a new Auditor General while current AG Doug Wylie offers to extend his term for two more years, creating political tension and uncertainty around financial oversight.
CPAB Appoints Sonny Randhawa as Incoming CEO
The Canadian Public Accountability Board appoints Sonny Randhawa as new CEO, bringing extensive financial regulation experience to strengthen audit oversight across Canada.
Top FDA Drug Official Resigns Amid Federal Probe
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Ardena Appoints Chief Quality and Information Officers
Ardena strengthens its leadership with strategic hires of Chief Quality Officer and Chief Information Officer to drive operational excellence and digital transformation in pharmaceutical services.
Kimberly-Clark Buys Tylenol Maker in $48.7B Deal
In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.
Kimberly-Clark Buys Tylenol Maker Kenvue for $4.87B
In a landmark healthcare deal, Kimberly-Clark acquires Kenvue, the consumer health giant behind Tylenol, Band-Aid and Listerine, reshaping the North American healthcare landscape.
Blood Pressure Medication Recall Over Cancer Risk
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
Eli Lilly's Weight Loss Drugs Spark Billion-Dollar Bidding War
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Weight-Loss Pill Race Revolutionizes Healthcare Market
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
Boehringer Ingelheim Licenses Novel Autoimmune Treatment
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
Ex-Pharmacy Manager Guilty, Fined $5K for Multiple Violations
A former Melita pharmacy manager faces consequences after being convicted of multiple professional misconduct charges, including improper prescription practices and record-keeping failures.
Page 3 of 3